Clinical Trials
3 trialsNCT03038308 2024-06-04
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
Columbia University
Phase 1/2 Completed
NCT00939523 2020-01-22
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Cedars-Sinai Medical Center
Phase 2 Completed
NCT01620138 2016-08-22
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
Universidade Federal do Rio de Janeiro
Phase 2/3 Completed